Danaher (DHR) Stock Forecast & Price Prediction

Estimation of the future price movement of Danaher stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $220.76

Concensus $318.19


Low $265.00

Median $314.50

High $365.00

Based on analysts projections #DHR is expected to experience a positive growth trajectory over the next year.

The current average DHR price target, as estimated by these analysts, is $318.19.

The predictions for the future DHR stock price range from a low of $265.00 to a high of $365.00, highlighting the variability of market expectations for DHR.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

DHR stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Paul Knight
Loop Capital Markets
September 27, 2023 Buy 300.00 247.44
Credit Suisse January 5, 2023 Buy 300.00 266.37
Deutsche Bank December 14, 2022 Buy 310.00 276.68
Barclays November 29, 2022 Buy 277.00 261.16
Elizabeth Garcia
UBS
July 31, 2022 Buy 297.00 291.47
Deane Dray
RBC Capital
June 1, 2022 Buy 310.00 261.83
Catherine Schulte
Robert W. Baird
May 6, 2022 Buy 319.00 248.15
Timothy Daley
Wells Fargo
April 29, 2022 Buy 265.00 257.50
Deane Dray
RBC Capital
April 27, 2022 Buy 299.00 250.98
Catherine Schulte
Robert W. Baird
February 6, 2022 Buy 334.00 287.63
Matthew Sykes
Goldman Sachs
January 30, 2022 Buy 360.00 281.11
Brendan Luecke
Bernstein
January 16, 2022 Buy 365.00 293.31
Paul Knight
KeyBanc
October 22, 2021 Buy 345.00 312.90
Daniel Brennan
Cowen & Co.
October 22, 2021 Buy 360.00 312.90
Katie Tryhane
Credit Suisse
September 10, 2021 Buy 370.00 329.26
Derik De Bruin
Bank of America Securities
July 23, 2021 Buy 340.00 290.62
Robert Wasserman
Benchmark Co.
July 16, 2021 Buy 330.00 284.16
Erin Wright
Morgan Stanley
June 18, 2021 Buy 288.00 256.20
Liza Garcia
Wolfe Research
June 18, 2021 Buy 325.00 256.20

Danaher (DHR) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Danaher is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 07/12/2023

Altman Z-Score: 4.2

Piotroski Score: 5.0

ESG Score

Updated on: 07/12/2023

Environmental: 53.9

Social: 56.2

Governance: 61.9

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Neutral

ROA: Neutral

Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

DHR Discounted Cash Flow

Updated on: 07/12/2023

$224.270
Discounted Cash Flow Value


$220.760
Current Price

DHR Revenues by Segment

Updated on: 07/12/2023

Analytical And Physical Instrumentation
$28,460,000.00
Product Identification
$19,830,000.00
Research and medical products
$266,420,000.00

Revenue from Contract with Customer, Excluding Assessed Tax

DHR Revenues by Region

Updated on: 07/12/2023

North America
$139,680,000.00
Western Europe
$69,100,000.00

DHR Notes Due

Updated on: 07/12/2023

CIKExchangeTitle
0000313616 NYSE 1.350% Senior Notes due 2039
0000313616 NYSE 1.700% Senior Notes due 2024
0000313616 NYSE 1.200% Senior Notes due 2027
0000313616 NYSE 0.200% Senior Notes due 2026
0000313616 NYSE Floating Rate Senior Notes due 2022
0000313616 NYSE 2.500% Senior Notes due 2030
0000313616 NYSE 2.100% Senior Notes due 2026
0000313616 NYSE 0.450% Senior Notes due 2028
0000313616 NYSE 1.800% Senior Notes due 2049
0000313616 NYSE 0.750% Senior Notes due 2031

Danaher (DHR) Social Sentiments

Monitoring bullish and bearish sentiments towards Danaher on Twitter and Stocktwits could help to forecast an upward or downward trend in Danaher stock price.

No social results for DHR

Optimizing Returns: A Stock Forecast Analysis on Danaher Corporation's Growing Profits in Diagnostics and Research Sector

Danaher Corporation is a public company that operates in the Diagnostics and Research Sector. The company has a stock ticker of DHR and is known for its expertise in creating solutions for diagnostic challenges. The history of Danaher dates back to 1969 when it was founded as a real estate investment trust, but over the years, it has grown to... Read more

Capitalizing on Growth Potential: Stock Prediction of Danaher in Diagnostics & Research Sector

The Diagnostics & Research stock market sector is a field that specializes in the research, development, and production of diagnostic tools for healthcare professionals. With an increasing demand for quick and accurate diagnosis in healthcare settings, this market sector boasts stability and growth potential. Investors are continually on the lookout for promising stocks to place their money on with stock... Read more